Personalization That Respects Privacy: Rethinking Relevance in Healthcare

Pharmaceutical brands can proactively engage patients and providers using predictive AI to engage audiences based on what will likely happen

At MyHealthTeam’s all-company get-together in Nashville, we invited five pharma marketing experts from top agencies and biotechs to join me on a panel. We discussed the “New Marketing Playbook” for everything from rare disease launches to direct-to-patient models to innovative uses of AI with patients.

“Data is not created equally. Understanding the difference between zero-party and first-party data can be game-changing for pharma marketers. Below is a guide on how pharma marketers can reach more of the right people with less waste.”

“The Reuters Pharma USA conference, held this spring in Philadelphia, is one of the best conferences attended by and featuring pharma executives. Here are our notes on some of the top themes and actionable takeaways from the event.”

A distinguished group of marketing executives discuss the use of conversational AI tools and AI integration in pharma marketing.

How healthcare manufacturers can improve customer engagement, drive high-value activity and inform future strategy with conversational AI.

The way physicians and patients interact with conversational AI presents a new opportunity for brands to connect with customers on a deeper level.

Using Swoop’s predictive AI technology, marketers can target patients before they are diagnosed, progress to a new treatment or become non-adherent – and more.

As Google’s third-party cookies become obsolete, marketers should turn to privacy-safe targeting solutions based on real world data via Swoop.

Here’s why Swoop’s conversational AI is the safest and most effective option for healthcare customer digital interaction.